Daxor Corp

DXR05 Dec 2024
Healthcare
$9.4
-0.03 (-2.54%)
Lowest Today
$8.95
Highest Today
$9.4
Today’s Open
$9.4
Prev. Close
$9.44
52 Week High
$10.04
52 Week Low
$7.16
To Invest in Daxor Corp

Daxor Corp

Healthcare
DXR05 Dec 2024
-0.03 (-2.54%)
1M
3M
6M
1Y
5Y
Low
$8.95
Day’s Range
High
$9.4
8.95
52 Week Low
$7.16
52-Week Range
52 Week High
$10.04
7.16
1 Day
-
1 Week
-3.31%
1 month return
-1.84%
3 month return
-2.27%
6 month return
-3%
1 Year return
-
3 Years return
-
5 Years return
-1.73%
10 Years return
-
Institutional Holdings
Vanguard Group Inc
1.01
Vanguard Total Stock Mkt Idx Inv
1.01
Renaissance Technologies Corp
0.31
Keyes Stange & Wooten Wealth Management LLC
0.3
Bridgeway Ultra-Small Company Market
0.13
UBS Group AG
0.03
NT Quality SCC US Fund - L
0.01

Market Status

Fundamentals
Market Cap
45.69 mln
PB Ratio
1.4
PE Ratio
8.14
Enterprise Value
42.93 mln
Total Assets
34.87 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.
Organisation
Daxor Corp
Employees
0
Industry
Medical Instruments & Supplies
CEO
Mr. Michael Richard Feldschuh
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step